Fall 2022 Vol. 12 Issue 03
-
From the Editor-in-Chief
Cancer and AgingCancer cells exploit an aging "infrastructure" to threaten life in those 60 and older.
by William G. Nelson, MD, PhD
-
-
Your Cancer Guide
Thriving as a SurvivorLearn to live well in the years after cancer treatment.
by Hester Hill Schnipper
-
Caregiving With Confidence
Nurture a Circle of SupportLeaning on others can help to make you a better caregiver.
by K.J. Bannan
-
Policy Matters
A Call to Eliminate InequitiesThe AACR Cancer Disparities Progress Report highlights the progress being made toward cancer health equity and stresses the need to address this complex public health issue.
by Lisa A. Newman, MD, MPH
-
Caught in the MiddleAdolescents and young adults diagnosed with cancer often lag behind children and older adults in benefiting from treatment advances and social support.
by Cameron Walker
-
Chemo or Not?Tumor profiling tests that predict the likelihood of distant recurrence can help some women with early-stage, hormone receptor-positive breast cancer decide on treatments after surgery.
by Kris Conner
-
Taking Stock of CAR T-Cell TherapyFive years after the FDA approved the first CAR T-cell therapy, use of the treatment has expanded to many patients with blood cancer.
by Kendall K. Morgan
-
Survivor Profile
A Recovery MindsetResearcher and esophageal cancer survivor Laurie Betts leans into past lessons learned, including the value of service to others, to get through cancer.
by Lindsey Konkel Neabore
-
-
Q&A
Stay Engaged in LifeJournalist Helen Epstein’s memoir provides a candid account of nurturing her passions during treatment, even as the world shuttered its doors during the pandemic.
by Marci A. Landsmann
-
-
Get Involved
The Power of PlayPediatric cancer survivor Eric Newman launched the Roc Solid Foundation, which builds playsets for children who have cancer.
by Thomas Celona
-
Facts and Stats
Rules for Healthy LivingUpdated guideline reinforces the role of plant-based foods and heart-pumping activities for cancer survivors.
by Thomas Celona
FDA approval expands treatment options for people with metastatic breast cancer that expresses minimal levels of HER2.
by Sandra Gordon
Lessons Learned as a Caregiver and PatientAfter caring for her husband during his cancer treatment, Miriam Díaz-Gilbert was prepared to face her DCIS diagnosis.
by Miriam Díaz-Gilbert
Screening Options for People With Dense BreastsReports on breast density inform women of their status but raise questions about what to do next.
by Robin Roenker
Injection Immunotherapies Get FDA ApprovalGiving immunotherapy drugs as injections, rather than intravenously, means patients can spend less time in the hospital or treatment center.
by Laura Gesualdi-Gilmore
-
Inaugural AACR IO Conference Kicks Off With Celebration of Immune CheckpointsImmune checkpoint icons James Allison and Arlene Sharpe shared their journeys and a look ahead on the opening night of the inaugural AACR IO conference.
-
A New Resource Provides a Sanctuary for Black TNBC PatientsThe Black TNBC Sanctuary was created to help Black women with triple-negative breast cancer get answers about their diagnosis and care.
Dr. Humberto M. Guiot: Targeting Pancreatic Cancer in a Community-Based Clinical Trial
